Taro received FDA approval for four dosages of the tablets: 250 mg, 500 mg, 750 mg, and 1000 mg. According to industry sources, levetiracetam tablets had over $700 million in US sales in 2009.
Taro's share closed at $10.01 on Wall Street yesterday.
You comment was recieved and soon will be published.
Thank you for posting your comment, which will be reviewed for publication.
Load more comments